Details for Patent: 5,679,376
Summary for Patent: 5,679,376
| Title: | Simethicone containing pharmaceutical compositions |
| Abstract: | A solid oral dosage form for the treatment of gastrointestinal disorders comprising a therapeutically effective amount of a pharmaceutical suitable for the treatment of gastric disorders selected from the group consisting of cimetidine, ranitidine, famotidine, diphenoxylate, loperamide, loperamide-N-oxide, pharmaceutically acceptable salts thereof and combinations thereof; and a therapeutically effective amount of simethicone wherein the pharmaceutical and simethicone are separated by a barrier which is substantially impermeable to simethicone. |
| Inventor(s): | Charles A. Stevens, Michael R. Hoy, Edward J. Roche |
| Assignee: | Kenvue Brands LLC |
| Application Number: | US08/455,443 |
|
Patent Claim Types: see list of patent claims | Use; Compound; Dosage form; |
Drugs Protected by US Patent 5,679,376
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 5,679,376
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Brazil | 1100495 | ⤷ Start Trial | |||
| Brazil | 1100507 | ⤷ Start Trial | |||
| Canada | 2096575 | ⤷ Start Trial | |||
| Germany | 69315257 | ⤷ Start Trial | |||
| European Patent Office | 0571217 | ⤷ Start Trial | |||
| Spain | 2112387 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
